Cambrex Corporation (Cambrex) is a life sciences company that provides products and services worldwide to pharmaceutical and generic drug companies. The Company's products consist of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates produced under the United States Food and Drug Administration (FDA) current Good Manufacturing Practices (cGMP) for use in the production of prescription and over-the-counter drug products and other fine custom chemicals derived from organic chemistry. In January 2008, Cambrex acquired AS ProSyntest, an API research and development company.
Energetic, entrepreneurial and successful sales and marketing executive with consistent record of accomplishments over a 20+ year period at the regional, national and multinational level in the specialty fine chemical marketplace. Possesses a profound knowledge of pharmaceutical drug delivery and excipients for solid dosage applications (pharmaceutical and nutritional), dietary ingredients, cosmetic (skincare) active ingredients and key account management of multinational pharmaceutical and cosmetic customers. Specialties: Business development Pharmaceutical ingredients and excipients Drug Delivery systems